RF1AG086417
Project Grant
Overview
Grant Description
INDOLES FROM COMMENSAL MICROBIOTA PROMOTE MOBILITY DURING AGING - ABSTRACT: AGING IS ASSOCIATED WITH LOSS OF MOBILITY AND ALSO WITH DYSBIOSIS, BUT IT IS UNCLEAR WHAT MICROBIOTA PRODUCTS CONTRIBUTE TO HEALTH OR FRAILTY. WE IDENTIFIED INDOLE AND ITS DERIVATIVES AS MOLECULES SECRETED BY BENEVOLENT COMMENSAL BACTERIA THAT ACT ACROSS DIVERSE PHYLA (C. ELEGANS, DROSOPHILA, MICE) TO AUGMENT HEALTHSPAN AND ALLOW ANIMALS TO LIVE BETTER FOR LONGER. OUR PRELIMINARY AND PUBLISHED DATA SUGGEST THAT AS ANIMALS AGE, INDOLE ACTS VIA THE ARYL HYDROCARBON RECEPTOR [AHR] TO LIMIT SARCOPENIA AND MAINTAIN MOBILITY IN AGED ANIMALS; SPECIFICALLY, INDOLES LIMIT THE LOSS OF CRITICAL SARCOMERE PROTEINS AS WELL AS A- AND I-BANDS WITHIN THE MUSCLE SARCOMERE. CITING OUR WORK AS IMPETUS, A RECENT METABOLOMIC STUDY USING SAMPLES FROM THE OSTEOPOROTIC FRACTURES IN MEN [MROS] COHORT FOUND THAT LOSS OF INDOLE-PRODUCING BACTERIA REDUCED PLASMA INDOLE LEVELS AND CORRELATED WITH DECREASED MOBILITY IN AGED HUMANS. WE HYPOTHESIZE THAT INDOLE PROMOTES STABILITY OF MUSCLE PROTEINS ESSENTIAL FOR THE CONTRACTILE APPARATUS BY PROMOTING CHAPERONE-MEDIATED REFOLDING OF DAMAGED PROTEINS, OR BY REGULATING PROTEASOME ACTIVITY TO PROMOTE LOSS OF IRREPARABLE PROTEINS AND/OR LIMITING AGGREGATION OF DAMAGED PROTEINS. WE IDENTIFIED ANOTHER INDOLE-REGULATED PROCESS IN MUSCLES THAT MAY ALECT MOTILITY DURING AGING. SPECIFICALLY, INDOLE RESTORES YOUTHFUL EXPRESSION OF GENES ASSOCIATED WITH MITOCHONDRIAL RESPIRATORY FUNCTION AND ELICIENCY THAT FUEL MUSCLE ACTIVITY. INDOLE ALSO LIMITS MITOCHONDRIAL FRAGMENTATION IN AGING MUSCLE, A PROCESS ASSOCIATED WITH REDUCED ATP PRODUCTION AND INCREASED REACTIVE OXYGEN SPECIES [ROS] PRODUCTION. WE HYPOTHESIZE THAT DURING AGING, INDOLE (I) REGULATES THE PROTEOSTASIS MACHINERY, INCLUDING BOTH CHAPERONES AND THE UBIQUITIN-PROTEASOME SYSTEM [UPS], TO REFOLD OR ELIMINATE DAMAGED SARCOMERE PROTEINS AND PRESERVE MYOFIBRILS; AND (II) UPREGULATES MITOCHONDRIA RESPIRATION AND REDUCES ROS PRODUCTION, TO MAXIMIZE ATP PRODUCTION AND LIMIT DAMAGE TO SARCOMERES. OUR AIMS DETERMINE HOW INDOLE LIMITS SARCOMERE AND MITOCHONDRIAL DAMAGE, MAINTAINS MUSCLE MASS AND FUNCTION, AND PROMOTES MOBILITY DURING AGING. AIM 1 DETERMINES THE MECHANISM BY WHICH INDOLE LIMITS AGE-DEPENDENT LOSS OF EXISTING ASSEMBLED MYOFIBRILS VIA UPREGULATING THE LEVELS OF THE MYOSIN CHAPERONE UNC-45 AND THE UPS. AIM 2 DETERMINES HOW INDOLE MAINTAINS OR IMPROVES MITOCHONDRIAL FUNCTION AND MORPHOLOGY DURING AGING TO FUEL MUSCLE ACTIVITY AND LIMIT ROS DAMAGE TO MYOFIBRILS. AIM 3 USES GENETIC APPROACHES TO IDENTIFY ADDITIONAL CELLULAR PATHWAYS REGULATED BY INDOLE THAT PROMOTE MITOCHONDRIAL OR SARCOMERE STABILITY AND MOTILITY DURING AGING. WE USE GENETIC AND BIOCHEMICAL ANALYSIS IN THE NEMATODE CAENORHABDITIS ELEGANS, WHOSE STRIATED MUSCLES EXHIBIT SIGNIFICANT STRUCTURAL CONSERVATION WITH MAMMALS. IMPORTANTLY, AGING C. ELEGANS EXHIBIT LOSS OF MOBILITY AND CHANGES IN PROTEOSTASIS, INCLUDING LOSS OF THE CONTRACTILE APPARATUS AND MITOCHONDRIAL FUNCTION, CHARACTERISTIC FEATURES OF SARCOPENIA IN MAMMALS THAT ARE MITIGATED BY INDOLE. HERE, WE ALSO PROPOSE TO CORROBORATE OUR WORM RESULTS IN AGED MICE. TOGETHER, THESE STUDIES WILL PROVIDE MECHANISTIC INFORMATION ON HOW INDOLE DERIVED FROM COMMENSAL BACTERIA COUNTERACTS SARCOPENIA DURING AGING. THESE STUDIES ARE ESSENTIAL FOR DEVELOPING INDOLES AS BIOMARKERS FOR FRAILTY AND HEALTH, AND AS POSSIBLE THERAPEUTICS TO TREAT SARCOPENIA AND OTHER FORMS OF MUSCLE WASTING IN THE ELDERLY.
Awardee
Funding Goals
TO ENCOURAGE BIOMEDICAL, SOCIAL, AND BEHAVIORAL RESEARCH AND RESEARCH TRAINING DIRECTED TOWARD GREATER UNDERSTANDING OF THE AGING PROCESS AND THE DISEASES, SPECIAL PROBLEMS, AND NEEDS OF PEOPLE AS THEY AGE. THE NATIONAL INSTITUTE ON AGING HAS ESTABLISHED PROGRAMS TO PURSUE THESE GOALS. THE DIVISION OF AGING BIOLOGY EMPHASIZES UNDERSTANDING THE BASIC BIOLOGICAL PROCESSES OF AGING. THE DIVISION OF GERIATRICS AND CLINICAL GERONTOLOGY SUPPORTS RESEARCH TO IMPROVE THE ABILITIES OF HEALTH CARE PRACTITIONERS TO RESPOND TO THE DISEASES AND OTHER CLINICAL PROBLEMS OF OLDER PEOPLE. THE DIVISION OF BEHAVIORAL AND SOCIAL RESEARCH SUPPORTS RESEARCH THAT WILL LEAD TO GREATER UNDERSTANDING OF THE SOCIAL, CULTURAL, ECONOMIC AND PSYCHOLOGICAL FACTORS THAT AFFECT BOTH THE PROCESS OF GROWING OLD AND THE PLACE OF OLDER PEOPLE IN SOCIETY. THE DIVISION OF NEUROSCIENCE FOSTERS RESEARCH CONCERNED WITH THE AGE-RELATED CHANGES IN THE NERVOUS SYSTEM AS WELL AS THE RELATED SENSORY, PERCEPTUAL, AND COGNITIVE PROCESSES ASSOCIATED WITH AGING AND HAS A SPECIAL EMPHASIS ON ALZHEIMER'S DISEASE. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO EXPAND AND IMPROVE THE SBIR PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Georgia
United States
Geographic Scope
State-Wide
Related Opportunity
Emory University was awarded
Indole-Derived Microbiota Molecules Promote Mobility in Aging
Project Grant RF1AG086417
worth $3,251,767
from National Institute on Aging in September 2025 with work to be completed primarily in Georgia United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.866 Aging Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
9/1/25
Start Date
8/31/29
End Date
Funding Split
$3.3M
Federal Obligation
$0.0
Non-Federal Obligation
$3.3M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
RF1AG086417
SAI Number
RF1AG086417-2645050483
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NN00 NIH National Insitute on Aging
Awardee UEI
S352L5PJLMP8
Awardee CAGE
2K291
Performance District
GA-90
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Modified: 8/20/25